Cargando…
Erdafitinib for locally advanced or metastatic urothelial carcinoma
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128815/ https://www.ncbi.nlm.nih.gov/pubmed/35147178 http://dx.doi.org/10.1093/ajhp/zxac030 |
_version_ | 1784712623645786112 |
---|---|
author | Siefker-Radtke, Arlene O Loriot, Yohann |
author_facet | Siefker-Radtke, Arlene O Loriot, Yohann |
author_sort | Siefker-Radtke, Arlene O |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9128815 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-91288152022-05-25 Erdafitinib for locally advanced or metastatic urothelial carcinoma Siefker-Radtke, Arlene O Loriot, Yohann Am J Health Syst Pharm Letters Oxford University Press 2022-02-11 /pmc/articles/PMC9128815/ /pubmed/35147178 http://dx.doi.org/10.1093/ajhp/zxac030 Text en © American Society of Health-System Pharmacists 2022. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Letters Siefker-Radtke, Arlene O Loriot, Yohann Erdafitinib for locally advanced or metastatic urothelial carcinoma |
title | Erdafitinib for locally advanced or metastatic urothelial carcinoma |
title_full | Erdafitinib for locally advanced or metastatic urothelial carcinoma |
title_fullStr | Erdafitinib for locally advanced or metastatic urothelial carcinoma |
title_full_unstemmed | Erdafitinib for locally advanced or metastatic urothelial carcinoma |
title_short | Erdafitinib for locally advanced or metastatic urothelial carcinoma |
title_sort | erdafitinib for locally advanced or metastatic urothelial carcinoma |
topic | Letters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128815/ https://www.ncbi.nlm.nih.gov/pubmed/35147178 http://dx.doi.org/10.1093/ajhp/zxac030 |
work_keys_str_mv | AT siefkerradtkearleneo erdafitinibforlocallyadvancedormetastaticurothelialcarcinoma AT loriotyohann erdafitinibforlocallyadvancedormetastaticurothelialcarcinoma |